211: The significance of palifermin (Kepivance®) in reduction of oral mucositis (OM) incidence and acute graft versus host disease in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT)

Saved in:
Bibliographic Details
Published inBiology of blood and marrow transplantation Vol. 13; no. 2; pp. 77 - 78
Main Authors Nasilowska-Adamska, B, Rzepecki, P, Manko, J, Czyz, A, Markiewicz, M, Fedorowicz, I, Tomaszewska, A, Piatkowska-Jakubas, B, Wrzesien-Kus, A, Bieniaszewska, M, Duda, D, Halaburda, K, Szczepinski, A, Lange, A, Hellman, A, Robak, T, Skotnicki, A, Jedrzejczak, W.W, Walewski, J, Holowiecki, J, Komarnicki, M, Dmoszynska, A, Warzocha, K, Marianska, B
Format Journal Article
LanguageEnglish
Published Elsevier Inc 2007
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2006.12.215